Lotus Eye Hospital Dividend & Ex-dividend History

LOTUSEYE • Dividend Analysis
Latest Dividend
₹0.5
0.87% Yield • 2022-March
Annual Payment

Lotus Eye Hospital (LOTUSEYE) has paid dividends for 4 years, annual and an average yield of 1.47% (40.0% consistency). The last dividend was ₹0.5 per share (2022-March, 0.87% yield), peak yield 2.27%. Check Lotus Eye Hospital marketcap in USD to track the company's total market size over time.

Dividend Data Export

Dividend Summary

Latest Dividend ₹0.5
Average Dividend ₹0.5

Lotus Eye Hospital Dividend Per Share & Yield History

LOTUSEYE annual dividend per share (DPS) and dividend yield over 4 years.

Lotus Eye Hospital Dividend Payment History

LOTUSEYE ex-dividend dates, dividend per share, yield and payment type — 10 records. For the full company profile including live price and ratios, see Lotus Eye Hospital share price screener.

Year Period Dividend per Share Dividend Yield Payment Type
2026 March ₹0.00 0.00% Annual
2025 March ₹0.00 0.00% Annual
2024 March ₹0.00 0.00% Annual
2023 March ₹0.00 0.00% Annual
2022 March ₹0.50 0.87% Annual
2021 March ₹0.50 0.94% Annual
2020 March ₹0.00 0.00% Annual
2019 March ₹0.00 0.00% Annual
2018 March ₹0.50 2.27% Annual
2017 March ₹0.50 1.81% Annual

Frequently Asked Questions

Q: How much dividend does Lotus Eye Hospital pay?
Lotus Eye Hospital last paid a dividend of ₹0.5 with a yield of 0.87%. The company typically pays dividends annual.
Q: What is Lotus Eye Hospital dividend yield?
Lotus Eye Hospital has an average dividend yield of 1.47% based on historical data. The highest yield recorded was 2.27% and the lowest was 0.87%.
Q: How often does Lotus Eye Hospital pay dividends?
Lotus Eye Hospital typically pays dividends annual. The company has maintained a consistent payment frequency.
Q: Is Lotus Eye Hospital a good dividend stock?
Lotus Eye Hospital has paid dividends with 40.0% consistency over 10 years. The company has paid dividends in 4 out of 10 years tracked. Consider this alongside your investment goals and risk tolerance.